You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API methadone hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing methadone hydrochloride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
West-Ward Pharmaceuticals Corp DOLOPHINE methadone hydrochloride 0054-4218 CELLULOSE, MICROCRYSTALLINE
West-Ward Pharmaceuticals Corp DOLOPHINE methadone hydrochloride 0054-4218 MAGNESIUM STEARATE
West-Ward Pharmaceuticals Corp DOLOPHINE methadone hydrochloride 0054-4218 STARCH, CORN
Hikma Pharmaceuticals USA Inc DISKETS methadone hydrochloride 0054-4538 CELLULOSE, MICROCRYSTALLINE
Hikma Pharmaceuticals USA Inc DISKETS methadone hydrochloride 0054-4538 FD&C YELLOW NO. 6
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing methadone hydrochloride

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA methadone hydrochloride 0054-0392 ANHYDROUS CITRIC ACID
Hikma Pharmaceuticals USA methadone hydrochloride 0054-0392 CHERRY
Hikma Pharmaceuticals USA methadone hydrochloride 0054-0392 D&C RED NO. 33
Hikma Pharmaceuticals USA methadone hydrochloride 0054-0392 FD&C RED NO. 40
Hikma Pharmaceuticals USA methadone hydrochloride 0054-0392 GLYCERIN
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for methadone hydrochloride

Excipient focus: ALCOHOL

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BENZOIC ACID

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CHERRY

Excipient focus: CHLOROBUTANOL

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: D&C RED NO. 33

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

methadone hydrochloride drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Company Ingredient NDC
Hikma Pharmaceuticals USA methadone hydrochloride 0054-0392
Hikma Pharmaceuticals USA Inc methadone hydrochloride 0054-0709
Hikma Pharmaceuticals USA Inc methadone hydrochloride 0054-3553
Hikma Pharmaceuticals USA Inc methadone hydrochloride 0054-3555
West-Ward Pharmaceuticals Corp methadone hydrochloride 0054-4218
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: GLYCERIN

Excipient focus: HYDROCHLORIC ACID

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHYLPARABEN

Excipient focus: MONOBASIC POTASSIUM PHOSPHATE

methadone hydrochloride drug variants not containing MONOBASIC POTASSIUM PHOSPHATE

Company Ingredient NDC
Hikma Pharmaceuticals USA methadone hydrochloride 0054-0392
Hikma Pharmaceuticals USA Inc methadone hydrochloride 0054-0709
Hikma Pharmaceuticals USA Inc methadone hydrochloride 0054-3553
Hikma Pharmaceuticals USA Inc methadone hydrochloride 0054-3555
West-Ward Pharmaceuticals Corp methadone hydrochloride 0054-4218
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: POLOXAMER 188

Excipient focus: POLOXAMER 407

Excipient focus: POTASSIUM SORBATE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SACCHARIN SODIUM

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SORBIC ACID

Excipient focus: SORBITOL

Excipient focus: SORBITOL SOLUTION

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: STEARIC ACID

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group